Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: A multicenter prospective study
Số trang: 11
Loại file: pdf
Dung lượng: 1.08 MB
Lượt xem: 7
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
This study aimed to determine the effectiveness of liquid biopsy in detecting epidermal growth factor receptor (EGFR) mutations at diagnosis, disease progression, and intermediate stages. This prospective, multicenter, observational study included 30 patients with non-small cell lung cancer treated with afatinib, harboring a major EGFR mutation confirmed by tumor tissue biopsy
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Cell-free deoxyribonucleic acid Epidermal growth factor receptor Liquid biopsy Non-small cell lung cancer Epidermal growth factor receptor Tyrosine kinase inhibitorsGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 169 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 139 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 110 0 0 -
12 trang 89 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 37 0 0
-
11 trang 36 0 0
-
12 trang 34 0 0